GPI 2AAlternative Names: Anti-p24 Antisense
Latest Information Update: 07 Feb 2008
At a glance
- Originator Viventia Biotech
- Class Antisense oligonucleotides; Antivirals
- Mechanism of Action Virus replication inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections